Patterns of gene-specific and total transcriptional activity during the Plasmodium falciparum intraerythrocytic developmental cycle.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 2653245)

Published in Eukaryot Cell on January 16, 2009

Authors

Jennifer S Sims1, Kevin T Militello, Peter A Sims, Vishal P Patel, Jacob M Kasper, Dyann F Wirth

Author Affiliations

1: Department of Immunology and Infectious Diseases, Harvard School of Public Health, Harvard University, Boston, Massachusetts 02115, USA.

Articles citing this

The Apicomplexan AP2 family: integral factors regulating Plasmodium development. Mol Biochem Parasitol (2010) 1.74

Nucleosome landscape and control of transcription in the human malaria parasite. Genome Res (2010) 1.70

H2A.Z demarcates intergenic regions of the plasmodium falciparum epigenome that are dynamically marked by H3K9ac and H3K4me3. PLoS Pathog (2010) 1.47

Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests. PLoS One (2011) 1.35

A global transcriptional analysis of Plasmodium falciparum malaria reveals a novel family of telomere-associated lncRNAs. Genome Biol (2011) 1.32

MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. Proc Natl Acad Sci U S A (2014) 1.25

In silico and biological survey of transcription-associated proteins implicated in the transcriptional machinery during the erythrocytic development of Plasmodium falciparum. BMC Genomics (2010) 1.12

Analysis of the molecular mechanisms governing the stage-specific expression of a prototypical housekeeping gene during intraerythrocytic development of P. falciparum. J Mol Biol (2011) 0.93

Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication. Parasite Immunol (2012) 0.90

PfSRPK1, a novel splicing-related kinase from Plasmodium falciparum. J Biol Chem (2010) 0.89

Analysis of the spatial and temporal arrangement of transcripts over intergenic regions in the human malarial parasite Plasmodium falciparum. BMC Genomics (2013) 0.87

Protease-associated cellular networks in malaria parasite Plasmodium falciparum. BMC Genomics (2011) 0.83

Deep profiling of the novel intermediate-size noncoding RNAs in intraerythrocytic Plasmodium falciparum. PLoS One (2014) 0.80

Genome-wide analysis in Plasmodium falciparum reveals early and late phases of RNA polymerase II occupancy during the infectious cycle. BMC Genomics (2014) 0.79

Homopolymer tract organization in the human malarial parasite Plasmodium falciparum and related Apicomplexan parasites. BMC Genomics (2014) 0.77

Chromatin-driven de novo discovery of DNA binding motifs in the human malaria parasite. BMC Genomics (2011) 0.77

Triaging informative cis-regulatory elements for the combinatorial control of temporal gene expression during Plasmodium falciparum intraerythrocytic development. Parasit Vectors (2015) 0.76

Plasmodium parasites mount an arrest response to dihydroartemisinin, as revealed by whole transcriptome shotgun sequencing (RNA-seq) and microarray study. BMC Genomics (2015) 0.76

Cluster analysis of Plasmodium RNA-seq time-course data identifies stage-specific co-regulated biological processes and regulatory elements. F1000Res (2016) 0.75

Articles cited by this

A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61

Human malaria parasites in continuous culture. Science (1976) 59.70

Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89

Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol (1979) 23.90

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother (1979) 17.49

The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol (2003) 11.86

A proteomic view of the Plasmodium falciparum life cycle. Nature (2002) 10.65

Discovery of gene function by expression profiling of the malaria parasite life cycle. Science (2003) 10.57

Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science (1970) 6.39

A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science (2005) 5.99

A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell (1982) 5.08

The power of the 3' UTR: translational control and development. Nat Rev Genet (2003) 4.84

A genome-wide map of diversity in Plasmodium falciparum. Nat Genet (2006) 4.50

Regulation of sexual development of Plasmodium by translational repression. Science (2006) 4.15

Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature (2007) 3.69

Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res (2004) 3.63

Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains. Nucleic Acids Res (2005) 3.36

Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad Sci U S A (2008) 3.10

Genomic run-on evaluates transcription rates for all yeast genes and identifies gene regulatory mechanisms. Mol Cell (2004) 2.99

Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg (1993) 2.90

Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res (2006) 2.78

Comparative genomics of transcriptional control in the human malaria parasite Plasmodium falciparum. Genome Res (2004) 2.66

RNA interference in protozoan parasites. Cell Microbiol (2004) 2.29

Whole-genome analysis of mRNA decay in Plasmodium falciparum reveals a global lengthening of mRNA half-life during the intra-erythrocytic development cycle. Genome Biol (2007) 2.03

Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res (2004) 1.92

The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol (2005) 1.91

In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int J Parasitol (1996) 1.90

Developmental regulation of stage-specific ribosome populations in Plasmodium. Nature (1989) 1.80

Serial analysis of gene expression in Plasmodium falciparum reveals the global expression profile of erythrocytic stages and the presence of anti-sense transcripts in the malarial parasite. Mol Biol Cell (2001) 1.79

Transcription occurs in pulses in muscle fibers. Genes Dev (1998) 1.77

Imaging Drosophila gene activation and polymerase pausing in vivo. Nature (2007) 1.75

Distinct activated and non-activated RNA polymerase II complexes in yeast. EMBO J (1996) 1.68

Widespread distribution of antisense transcripts in the Plasmodium falciparum genome. Mol Biochem Parasitol (2004) 1.68

Prediction of the general transcription factors associated with RNA polymerase II in Plasmodium falciparum: conserved features and differences relative to other eukaryotes. BMC Genomics (2005) 1.53

In silico discovery of transcription regulatory elements in Plasmodium falciparum. BMC Genomics (2008) 1.48

PfMyb1, a Plasmodium falciparum transcription factor, is required for intra-erythrocytic growth and controls key genes for cell cycle regulation. J Mol Biol (2004) 1.42

The structure of the calmodulin gene of Plasmodium falciparum. Mol Biochem Parasitol (1991) 1.29

Epigenetics in Apicomplexa: control of gene expression during cell cycle progression, differentiation and antigenic variation. Curr Opin Microbiol (2007) 1.29

Nuclear run-on assays: assessing transcription by measuring density of engaged RNA polymerases. Methods Enzymol (1999) 1.22

Combinatorial gene regulation in Plasmodium falciparum. Trends Genet (2005) 1.22

Partial purification and properties of calf thymus deoxyribonucleic acid dependent RNA polymerase III. Biochemistry (1975) 1.21

A sequence element associated with the Plasmodium falciparum KAHRP gene is the site of developmentally regulated protein-DNA interactions. Nucleic Acids Res (1992) 1.19

Protein and nucleic acid synthesis during synchronized growth of Plasmodium falciparum. J Bacteriol (1984) 1.18

Identification of regulatory elements in the Plasmodium falciparum genome. Mol Biochem Parasitol (2004) 1.18

Germline chromatin. WormBook (2006) 1.15

Mechanisms of gene regulation in Plasmodium. Am J Trop Med Hyg (2007) 1.15

RNA polymerase II synthesizes antisense RNA in Plasmodium falciparum. RNA (2005) 1.15

Mapping of the Plasmodium falciparum multidrug resistance gene 5'-upstream region, and evidence of induction of transcript levels by antimalarial drugs in chloroquine sensitive parasites. Mol Microbiol (2003) 1.13

Transcription mapping of a 100 kb locus of Plasmodium falciparum identifies an intergenic region in which transcription terminates and reinitiates. EMBO J (1992) 1.12

Time-course of synthesis, transport and incorporation of a protein identified in purified membranes of host erythrocytes infected with a knob-forming strain of Plasmodium falciparum. Mol Biochem Parasitol (1984) 1.09

Discovering regulatory motifs in the Plasmodium genome using comparative genomics. Bioinformatics (2008) 1.08

Regulatory motifs uncovered among gene expression clusters in Plasmodium falciparum. Mol Biochem Parasitol (2007) 1.06

Transcriptional control and gene silencing in Plasmodium falciparum. Cell Microbiol (2008) 1.04

Recombinant and native Plasmodium falciparum TATA-binding-protein binds to a specific TATA box element in promoter regions. Mol Biochem Parasitol (2005) 1.03

Antisense RNA and RNAi in protozoan parasites: working hard or hardly working? Mol Biochem Parasitol (2007) 1.02

Stage specific expression of proliferating cell nuclear antigen and DNA polymerase delta from Plasmodium falciparum. Mol Biochem Parasitol (1996) 1.00

Stage-specific sensitivity of Plasmodium falciparum to antifolates. Z Parasitenkd (1986) 0.98

Mutational analysis identifies a five base pair cis-acting sequence essential for GBP130 promoter activity in Plasmodium falciparum. Mol Biochem Parasitol (1999) 0.97

Stage-dependent toxicity of N-acetyl-glucosamine to Plasmodium falciparum. J Protozool (1985) 0.96

Nuclear run-on analysis of var gene expression in Plasmodium falciparum. Mol Biochem Parasitol (2007) 0.91

Transcription reactivation steps stimulated by oocyte maturation in C. elegans. Dev Biol (2006) 0.90

Shared epigenetic mechanisms control virulence factors in protozoan parasites. Curr Opin Microbiol (2007) 0.89

A 24 bp cis-acting element essential for the transcriptional activity of Plasmodium falciparum CDP-diacylglycerol synthase gene promoter. Mol Biochem Parasitol (2002) 0.88

Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinase. Mol Biochem Parasitol (2006) 0.87

The DNA polymerase delta promoter from Plasmodium falciparum contains an unusually long 5' untranslated region and intrinsic DNA curvature. Mol Biochem Parasitol (2001) 0.86

Cell cycle-dependent regulation of RNA polymerase II basal transcription activity. Nucleic Acids Res (1995) 0.85

Distinct and stage specific nuclear factors regulate the expression of falcipains, Plasmodium falciparum cysteine proteases. BMC Mol Biol (2008) 0.83

Expression of a recombinant IRP-like Plasmodium falciparum protein that specifically binds putative plasmodial IREs. Mol Biochem Parasitol (2003) 0.83

Stage-specific merozoite surface protein 2 antisense transcripts in Plasmodium falciparum. Mol Biochem Parasitol (2002) 0.81

Stage-specific protein synthesis by asexual blood stage parasites of Plasmodium falciparum. Mol Biochem Parasitol (1983) 0.81

An enhancer-like region regulates hrp3 promoter stage-specific gene expression in the human malaria parasite Plasmodium falciparum. Biochim Biophys Acta (2007) 0.80

The structure and role of RNA polymerases in Plasmodium. Parasitol Today (1991) 0.76

Rhythmic changes in transcriptional activity during the development of potato tubers. Planta (1979) 0.76

Articles by these authors

A genome-wide map of diversity in Plasmodium falciparum. Nat Genet (2006) 4.50

A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog (2006) 2.92

High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob Agents Chemother (2006) 2.70

Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes. Proc Natl Acad Sci U S A (2012) 2.59

Observation of individual microtubule motor steps in living cells with endocytosed quantum dots. J Phys Chem B (2005) 2.55

A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking. Malar J (2008) 2.54

Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol (2009) 2.23

Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia. J Infect Dis (2007) 2.11

Genome-wide SNP genotyping highlights the role of natural selection in Plasmodium falciparum population divergence. Genome Biol (2008) 2.00

Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Gene (2008) 1.89

Geographic structure of Plasmodium vivax: microsatellite analysis of parasite populations from Sri Lanka, Myanmar, and Ethiopia. Am J Trop Med Hyg (2010) 1.69

Widespread distribution of antisense transcripts in the Plasmodium falciparum genome. Mol Biochem Parasitol (2004) 1.68

Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum. PLoS Genet (2011) 1.68

In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am J Trop Med Hyg (2002) 1.66

Hybrid selection for sequencing pathogen genomes from clinical samples. Genome Biol (2011) 1.61

Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite. Proc Natl Acad Sci U S A (2012) 1.58

Excess polymorphisms in genes for membrane proteins in Plasmodium falciparum. Science (2002) 1.52

A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J Infect Dis (2011) 1.49

In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins. J Infect Dis (2005) 1.46

Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model. J Biol Chem (2010) 1.46

Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. Nat Chem Biol (2012) 1.46

Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. J Med Chem (2009) 1.42

Harnessing genomics and genome biology to understand malaria biology. Nat Rev Genet (2012) 1.41

Organelle tracking in a living cell with microsecond time resolution and nanometer spatial precision. Chemphyschem (2008) 1.41

Genetic surveillance detects both clonal and epidemic transmission of malaria following enhanced intervention in Senegal. PLoS One (2013) 1.40

Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J Biol Chem (2008) 1.34

Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob Agents Chemother (2012) 1.30

Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies. BMC Genet (2010) 1.24

On the road to eliminate malaria in Sri Lanka: lessons from history, challenges, gaps in knowledge and research needs. Malar J (2014) 1.24

Low-complexity regions in Plasmodium falciparum: missing links in the evolution of an extreme genome. Mol Biol Evol (2010) 1.23

Plasmodium falciparum: genome wide perturbations in transcript profiles among mixed stage cultures after chloroquine treatment. Exp Parasitol (2007) 1.21

Gene conversion as a source of nucleotide diversity in Plasmodium falciparum. Mol Biol Evol (2003) 1.19

A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials--increased sensitivity of P. falciparum to chloroquine in Senegal. Am J Trop Med Hyg (2010) 1.18

Identification of regulatory elements in the Plasmodium falciparum genome. Mol Biochem Parasitol (2004) 1.18

RNA polymerase II synthesizes antisense RNA in Plasmodium falciparum. RNA (2005) 1.15

Drug-induced alterations in gene expression of the asexual blood forms of Plasmodium falciparum. Mol Microbiol (2003) 1.15

The paradoxical population genetics of Plasmodium falciparum. Trends Parasitol (2002) 1.14

Mapping of the Plasmodium falciparum multidrug resistance gene 5'-upstream region, and evidence of induction of transcript levels by antimalarial drugs in chloroquine sensitive parasites. Mol Microbiol (2003) 1.13

Genetic diversity and selection at the Plasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol Biol Evol (2007) 1.12

Polyadenylation regulates the stability of Trypanosoma brucei mitochondrial RNAs. J Biol Chem (2003) 1.11

Molecular analysis of erythrocyte invasion in Plasmodium falciparum isolates from Senegal. Infect Immun (2007) 1.11

Duplication, gene conversion, and genetic diversity in the species-specific acyl-CoA synthetase gene family of Plasmodium falciparum. Mol Biochem Parasitol (2006) 1.11

Colorimetric high-throughput screen for detection of heme crystallization inhibitors. Antimicrob Agents Chemother (2009) 1.06

Regulatory motifs uncovered among gene expression clusters in Plasmodium falciparum. Mol Biochem Parasitol (2007) 1.06

Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins. Proc Natl Acad Sci U S A (2013) 1.05

Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance. Proc Natl Acad Sci U S A (2013) 1.05

Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors. Chem Biol (2011) 1.04

Pre-amplification methods for tracking low-grade Plasmodium falciparum populations during scaled-up interventions in Southern Zambia. Malar J (2014) 1.01

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa. Malar J (2006) 1.01

Genomic sequencing of Plasmodium falciparum malaria parasites from Senegal reveals the demographic history of the population. Mol Biol Evol (2012) 1.00

In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal. Parasitol Res (2005) 1.00

Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors. Bioorg Med Chem Lett (2008) 1.00

Malaria life cycle intensifies both natural selection and random genetic drift. Proc Natl Acad Sci U S A (2013) 0.99

Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae. Antimicrob Agents Chemother (2002) 0.98

Analysis of pfhrp2 genetic diversity in Senegal and implications for use of rapid diagnostic tests. Malar J (2014) 0.97

Improving malaria control in West Africa: interruption of transmission as a paradigm shift. Acta Trop (2011) 0.96

SNP genotyping identifies new signatures of selection in a deep sample of West African Plasmodium falciparum malaria parasites. Mol Biol Evol (2012) 0.95

Application of genomics to field investigations of malaria by the international centers of excellence for malaria research. Acta Trop (2011) 0.95

In vivo transcriptional profiling of Plasmodium falciparum. Malar J (2004) 0.94

In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes. J Infect Dis (2012) 0.94

Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal. Parasitol Res (2012) 0.92

Murine cell line model of proneural glioma for evaluation of anti-tumor therapies. J Neurooncol (2013) 0.91

Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes. Acta Trop (2011) 0.91

A new reporter gene for transient transfection of Plasmodium falciparum. Parasitol Res (2002) 0.90

Target-locking acquisition with real-time confocal (TARC) microscopy. Opt Express (2007) 0.90

Nuclear repositioning precedes promoter accessibility and is linked to the switching frequency of a Plasmodium falciparum invasion gene. Cell Host Microbe (2012) 0.89

Biological revelations. Nature (2002) 0.89

Human cerebral malaria and Plasmodium falciparum genotypes in Malawi. Malar J (2012) 0.88

Vitreous cryopreservation maintains the viscoelastic property of human vascular grafts. FASEB J (2006) 0.87

Digital polymerase chain reaction in an array of femtoliter polydimethylsiloxane microreactors. Anal Chem (2012) 0.86

Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum. Antimicrob Agents Chemother (2011) 0.86

Linker scanning mutagenesis of the Plasmodium gallinaceum sexual stage specific gene pgs28 reveals a novel downstream cis-control element. Mol Biochem Parasitol (2003) 0.86

Pulmonary Kaposi sarcoma in AIDS. Mayo Clin Proc (2012) 0.86

Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal. Parasitol Res (2008) 0.86

Development of a fluorescence polarization based assay for histone deacetylase ligand discovery. Bioorg Med Chem Lett (2008) 0.85

Localization and activity of multidrug resistance protein 1 in the secretory pathway of Leishmania parasites. Mol Microbiol (2004) 0.84

Genomic heterogeneity in the density of noncoding single-nucleotide and microsatellite polymorphisms in Plasmodium falciparum. Gene (2006) 0.84

Analysis of the genetic diversity of the Plasmodium falciparum multidrug resistance gene 5' upstream region. Am J Trop Med Hyg (2005) 0.84

Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents. J Med Chem (2014) 0.83

Aminoazabenzimidazoles, a novel class of orally active antimalarial agents. J Med Chem (2014) 0.83

Modulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugs. Antimicrob Agents Chemother (2013) 0.82

Enrichment of reticulocytes from whole blood using aqueous multiphase systems of polymers. Am J Hematol (2014) 0.81

Secreted antibody is required for immunity to Plasmodium berghei. Infect Immun (2008) 0.81

A concise silylamine approach to 2-amino-3-hydroxy-indoles with potent in vivo antimalaria activity. Org Lett (2010) 0.80

A genomic and evolutionary approach reveals non-genetic drug resistance in malaria. Genome Biol (2014) 0.78

Distribution pattern of Plasmodium falciparum chloroquine transporter (pfcrt) gene haplotypes in Sri Lanka 1996-2006. Am J Trop Med Hyg (2011) 0.78

Nucleospora cyclopteri n. sp., an intranuclear microsporidian infecting wild lumpfish, Cyclopterus lumpus L., in Icelandic waters. Parasit Vectors (2013) 0.77

Variable SNP density in aspartyl-protease genes of the malaria parasite Plasmodium falciparum. Gene (2006) 0.77

Rapid and robust detection methods for poison and microbial contamination. J Agric Food Chem (2012) 0.76

Papua New Guinea needs law and order above all. BMJ (2003) 0.75